Navigation Links
Drug Found Ineffective Against Lung Disease
Date:6/30/2009

People with idiopathic pulmonary fibrosis gain no survival benefit, research finds,,

MONDAY, June 29 (HealthDay News) -- Treatment with interferon gamma-1b (Ifn-g1b) does not improve survival in people with a fatal lung disease called idiopathic pulmonary fibrosis, according to a study that was halted early after no benefit to participants was found.

Previous research had suggested that Ifn-g1b might benefit people with idiopathic pulmonary fibrosis, particularly those with mild to moderate disease.

The new study included 826 people, ages 40 to 79, who lived in Europe and North America. They were given injections of either 200 micrograms of Ifn-g1b (551 people) or a placebo (275) three times a week.

After a median of 64 weeks, 15 percent of those in the Ifn-g1b group and 13 percent in the placebo group had died. Symptoms such as flu-like illness, fatigue, fever and chills were more common among those in the Ifn-g1b group than in the placebo group. The two groups had similar rates of serious side effects, the researchers found.

"We cannot recommend treatment with interferon gamma-1b since the drug did not improve survival for patients with idiopathic pulmonary fibrosis, which refutes previous findings from subgroup analyses of survival in studies of patients with mild-to-moderate physiological impairment of pulmonary function," Dr. Talmadge E. King Jr., of the University of California, San Francisco, and colleagues wrote in the study published online and in an upcoming print issue of The Lancet.

The negative findings of this study "should be regarded as definite, [but] they should not discourage patients to participate in one of the several clinical trials currently underway to find effective treatments for this devastating disease," Dr. Demosthenes Bouros, of the Democritus University of Thrace in Greece, wrote in an accompanying editorial.

Bouros added that people deemed suitable "should be enrolled early in the transplantation list, which is today the only mode of treatment that prolongs survival."

More information

The U.S. National Heart, Lung and Blood Institute has more about idiopathic pulmonary fibrosis.



-- Robert Preidt



SOURCE: The Lancet, news release, June 29, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Sudden Cardiac Arrest Foundation Mourns the Loss of Michael Jackson
2. The AGA Foundation awards grant to Dr. Michael Choi to further his research on carcinoid tumors
3. New piece found in colorectal cancer puzzle
4. AUA Foundation announces 2009 Research Scholar Program award winners
5. AUA Foundation names the 2009 Astellas Rising Stars in Urology award winners
6. Jennifer Dodson, M.D., named 2009 AUA Foundation/NIDDK/NCI Surgeon-Scientist Award winner
7. The Crohns & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners
8. Elizabeth Edwards to Deliver Keynote Address at Patient Advocate Foundations 10th Annual Patient Congress
9. Virtuosant Technology Offers Virtuosant Foundation Portal™ for Free
10. The United Nations Foundation Joins White House Initiative to Encourage Public Service
11. Children's National Medical Center Honors The Children's Cancer Foundation for Commitment to Area Kids
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Found Ineffective Against Lung Disease
(Date:2/9/2016)... ... February 09, 2016 , ... United Methodist Communications ... of Prevention,ā€ an animated video designed to prevent the next widespread ... the video are being distributed throughout Togo, Liberia, Sierra Leone, Nigeria, Côte dā€™Ivoire ...
(Date:2/9/2016)... Santa Rosa, California (PRWEB) , ... February 09, 2016 , ... ... been rated one of the highest preliminary data vendors in the latest KLAS report, ... 15 years, i2i has led the developing market for population health management (PHM). ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... has officially been won. A team from 21st Century Medicine (21CM) ( http://www.21cm.com/ ... to preserve the delicate neural circuits of an intact rabbit brain for extremely ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory Consortium ... . The site houses a wealth of federal resources that businesses can leverage ... called technology transfer (T2). As a network of over 300 federal laboratories, the ...
(Date:2/8/2016)... ... February 08, 2016 , ... Coast Dental has a new way to help ... Month and family dentist Yvonne Dorrian, DMD, is hosting a free seminar on Friday, ... next to Target at 1207 North Peachtree Parkway in Peachtree City. Dr. Dorrian will ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 9, 2016 The global prefilled syringes market ... is expected to grow with a CAGR of 12.9% ... syringes segment dominated the global prefilled syringes market, with ... --> The global market of prefilled syringes ... increasing geriatric population, increasing demand for vaccines, increasing prevalence ...
(Date:2/9/2016)... Feb. 9, 2016 The new report "Global Blood Monitoring & Cardiac ... Research & Consulting group reveals that global market for blood monitoring ... 2014 and expected to grow to US$ 24,830.1 million by 2019 ... North America , Europe , ... Middle-East and Africa . The ...
(Date:2/9/2016)... Calif. , Feb. 9, 2016  Increasingly, health ... monitoring their vital signs with wireless technology. With the ... can automate patient oversight and remotely detect problems before ... vital signs across in-hospital environments. the ... the United States . --> ...
Breaking Medicine Technology: